2010PHAC 四价(A,C,Y,W135)脑膜炎球菌结合疫苗省和地区的使用建议
2010PHAC Advice for Consideration of Quadrivalent (A, C, Y, W135) Meningococcal Conjugate Vaccine, for use by Provinces and Territories
2010-01-01
The Centre for Immunization and Respiratory Infections of the Public Health Agency of Canada, through a contract with Dr. Philippe De Wals from the Public Health Research Unit, Quebec University Hospital Research Centre, requested an evaluation of the quadrivalent meningococcal vaccine using the Erickson, De Wals and Farand Analytical Framework. This report is primarily based on the evaluation provided by Dr. De Wals and represents available epidemiological and economical information up to Sept.2007. The information on the burden of disease and the vaccine characteristics has been updated in a statement from the National Advisory Committee on Immunization (NACI) in 2009.The scientific review, critical analysis and expert opinion presented by Dr. De Wals in this report are acknowledged.加拿大公共卫生署2010年发布的关于脑膜炎结合疫苗的使用指南。